| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/15/2006 | EP1633370A2 Combination of an aldosterone receptor antagonist and an anti-obesity agent |
| 03/15/2006 | EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 03/15/2006 | EP1633343A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers |
| 03/15/2006 | EP1633340A2 Compounds for the treatment of metabolic disorders |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1461040B1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 03/15/2006 | EP1451577A4 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1404303A4 Stable pharmaceutical compositions containing pravastatin |
| 03/15/2006 | EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | EP1162997B1 Staphylococcus antigen and vaccine |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP0939590B1 Nucleic acids for use in gene therapy involving intestinal cell gene expression |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | EP0804438B1 Tricyclic benzazepine vasopressin antagonists |
| 03/15/2006 | CN1747934A Crystalline forms of pitavastatin calcium |
| 03/15/2006 | CN1747928A Acylated aminopropanediols and analogues and therapeutic uses thereof |
| 03/15/2006 | CN1747734A Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 03/15/2006 | CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 03/15/2006 | CN1746171A Heterocyclic hepyramine derivative, its preparation and use thereof |
| 03/15/2006 | CN1746164A Protein antagonist with water channel |
| 03/15/2006 | CN1745826A Chinese medicinal for treating heart disease |
| 03/15/2006 | CN1745818A Pill for treating coronary heart disease |
| 03/15/2006 | CN1745817A Medicine for treating cerebral arteriosclerosis |
| 03/15/2006 | CN1745809A Liuwei Dihuang effervescent tablet and its preparation thereof |
| 03/15/2006 | CN1745804A Use of medicine containing Danshen Root inpreparing medicine against aspirin |
| 03/15/2006 | CN1745798A Granular preparation with pure Chinese medicine for treating hypertension and hyperlipemia and arterial sclerosis |
| 03/15/2006 | CN1745795A Medicine for preventing coronary heart disease and its preparation |
| 03/15/2006 | CN1745791A Use of medicinal composition |
| 03/15/2006 | CN1745781A Externally-applied chinese medicinal preparation for treating nervus and intestinal diseases |
| 03/15/2006 | CN1745780A Use of composition against aspirin |
| 03/15/2006 | CN1745779A Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease |
| 03/15/2006 | CN1745772A Chinese medicine composition for treating cardiovascular disease and preparation thereof |
| 03/15/2006 | CN1745771A Compound Chinese medicine for treating heart disease |
| 03/15/2006 | CN1745769A Use of medicine composition containing Milkvetch Root |
| 03/15/2006 | CN1745768A Use of medicine containing Milkvetch Root against aspirin |
| 03/15/2006 | CN1745767A Use of depot containing Chuanxiong against aspirin |
| 03/15/2006 | CN1745764A Use of depot containing safflower against aspirin |
| 03/15/2006 | CN1245508C Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 03/15/2006 | CN1245495C Pagodatree flower healthcare liquor and its preparation method |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245404C Mercaptoacetylamide derivatives, process for their preparation and use thereof |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245400C N-substituted benzothiophenesulfonamide derivatives |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245389C Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245383C Process for preparing zofenopril |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245197C Chinese medicine preparation for treating coronary heart disease and viral myocarditis |
| 03/15/2006 | CN1245190C Hemiplegia hypertension and contraceptive treating plaster |
| 03/15/2006 | CN1245183C Traditional Chinese medicinal plaster for treating angiitis |
| 03/15/2006 | CN1245180C Hypertension treating traditional Chinese medicine preparation and its preparing process |
| 03/15/2006 | CN1245172C Uses ofroot of Co donopsis Pilosula-astragalus composition in treating ischemic heart disease |
| 03/15/2006 | CN1245170C Health care composition for preventing and treating cadiac vascular diseases and its use |
| 03/15/2006 | CN1245168C Storax and baras camphor oral disintegration tablet and its preparing process |
| 03/15/2006 | CN1245167C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 03/15/2006 | CN1245163C Puerarin dispersing tablet composition and its preparation method |
| 03/15/2006 | CN1245160C Compound pressure-reduction preparation containing indapamide and angiotensin converzyme inhibitor |
| 03/15/2006 | CN1245159C Use of hydroxy saflor yellow pigment A in preparing medicine for treating and preventing cardiovascular and cerebrovascular diseases |
| 03/15/2006 | CN1245157C Novel fatty derivative for treatment of diabetes |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012145 Method |
| 03/14/2006 | US7012099 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | US7012076 Quinazoline-4-sulfonamide derivatives |
| 03/14/2006 | US7012074 Use in particular atrial and ventricular arrhythmias; e.g. 1-cyano-1-methylethyl 8-(2-amino-4-(4-cyanophenoxy)butyl)-3,8-diazabicyclo(3.2.1)octane-3-carboxylate |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011854 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 03/14/2006 | US7011828 Regeneration cells of nervous system |
| 03/14/2006 | CA2375430C C-pyrazole a2a receptor agonists |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2357687C New pyridazine endothelin antagonists |
| 03/14/2006 | CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 03/14/2006 | CA2268796C Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006026555A2 Neuroprotective effect of solubilized udca in focal ischemic model |
| 03/09/2006 | WO2006025889A2 Inhibition of atherosclerosis by diindolylmethane analogs |
| 03/09/2006 | WO2006025598A1 Suppressant for cerebral infarction attributed to long-time ischemia |
| 03/09/2006 | WO2006025070A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 03/09/2006 | WO2006024627A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2005082927A3 Antihypertensive peptides |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |